Cigna Group $CI Shares Acquired by King Wealth Management Group

King Wealth Management Group lifted its position in shares of Cigna Group (NYSE:CIFree Report) by 70.3% in the third quarter, Holdings Channel reports. The firm owned 9,692 shares of the health services provider’s stock after purchasing an additional 4,000 shares during the period. King Wealth Management Group’s holdings in Cigna Group were worth $2,794,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its position in shares of Cigna Group by 1.1% in the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after acquiring an additional 123,479 shares in the last quarter. Dodge & Cox boosted its position in Cigna Group by 0.7% during the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock worth $2,958,893,000 after purchasing an additional 60,877 shares during the period. Norges Bank acquired a new stake in Cigna Group in the 2nd quarter valued at $1,110,426,000. Arrowstreet Capital Limited Partnership increased its holdings in Cigna Group by 24.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after purchasing an additional 492,045 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Cigna Group by 0.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock valued at $678,652,000 after purchasing an additional 15,014 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 0.3%

Shares of NYSE:CI opened at $290.57 on Wednesday. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The company has a fifty day simple moving average of $277.96 and a 200 day simple moving average of $283.95. The firm has a market cap of $77.62 billion, a PE ratio of 13.10, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s payout ratio is 28.13%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CI. The Goldman Sachs Group decreased their target price on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. Leerink Partners boosted their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Robert W. Baird lowered their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Finally, Mizuho set a $325.00 target price on shares of Cigna Group in a research note on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $330.63.

Read Our Latest Stock Analysis on CI

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.